[Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway
Affiliations: Department of Anesthesiology, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China, Department of Oncology, The First Affiliated Hospital of Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China, Department of Hepatobiliary Surgery and Medical Oncology, Guilin Medical university, Affiliated Hospital, Guilin, Guangxi 541001, P.R. China
- Published online on: February 20, 2023 https://doi.org/10.3892/or.2023.8505
- Article Number: 68
Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Oncol Rep 33: [Related article:] 840–848, 2015; DOI: 10.3892/or.2014.3626
Subsequent to the publication of the above article, a concerned reader drew to our attention that the flow cytometric plots shown in Fig. 2 had previously appeared in another article published in the journal Oncology Reports [Huang G, Tang B, Tang K, Dong X, Deng J, Liao L, Liao Z, Yang H and He S: Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway. Oncol Rep 31: 2377–2384, 2014], suggesting that data purportedly showing results obtained under different experimental conditions had been derived from the same original source.
Given the errors that were identified in the compilation of Fig. 2 in this article, and the fact that all the data in this figure had been re-used from a previously published source, the Editor of Oncology Reports has decided that this article should be retracted from the publication owing to a lack of overall confidence in the presented data. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience that might result from the retraction of this article.